Backgrounds STEMI management is a public healthcare priority. Prompt reperfusion leads to a decrease in mortality and morbidities induced by myocardial necrosis. Every year, pre-hospital medical teams at Lille University Hospital handle almost one hundred and fifty STEMI. These patients need a reperfusion strategy either with a pre-hospital intra venous thrombolysis or a Percutaneous Coronary Intervention (PCI) in catheterism laboratory (cath-lab). Program This study is a cross-disciplinary professional practices evaluation between SAMU 59 and Lille University Hospital9s Cardiology Intensive-Care Unit. A retrospective analyse of medical data was done. We have made a review of medical data from ESTIM registry involving SAMU 59 since 2001. During the first 6 months of 2006, twenty medical records were random drawn. These data were compared with HAS guidelines in Acute Coronary Syndromes. Emergency Medical Physicians and Cardiologists daily implicated in STEMI support did analyse these data. Reperfusion rate, strategy of reperfusion and delays regarding the strategy were analysed. Results 90% of patients received Aspirin (ASA). Reperfusion rate is about 75%: 12 pre-hospital intravenous thrombolysis, 3PCI, five patients with no reperfusion. In case of thrombolysis, thrombolytic was administrated within 30 min after ECG diagnosis in 100% of cases. In case of PCI, patients did not directly reach the cath-lab: the 90 min average delay recommended in guidelines was therefore never respected. Clinical guidance for STEMI patients has thus been revised. Patients needing PCI should be directly admitted to the cath-lab. Public and private hospital partnership has been strengthened so that cath-lab availability was increased. A second look was performed with the same data, reviewing 18 medical records. ASA has been administrated in 100% of cases. Reperfusion rate is about 100%. Twelve patients received pre-hospital intravenous thrombolysis and 12 patients were admitted to cath-lab to undergo PCI. For those PCI occurred patients, in 50% of cases, delay between ECG diagnosis and balloon inflation was under 90 min. The other 6 PCI performed on patients after 90 min resulted in rhythmic and hemodynamic complications during transportation to hospital, needing Intensive-Care Unit first. Conclusion Rating scales have been validated by the HAS in 2008, and provided for every physician willing to assess professional practices. It enabled us to focus on consensual indicators. STEMI reperfusion is a challenge against time. All the actors are involved: the call-center emergency physician who sets off and coordinates resources, the cardiologist who will perform PCI, the pre-hospital emergency physician who diagnoses STEMI. Evaluation of professional practices allowed to detect weakness of STEMI management system in which choice of a reperfusion strategy and delay linked to this strategy directly impact early mortality. The choice of a reperfusion strategy suited to each patient and its environment is a guarantee of quality in management of STEMI. Objectif(s), contexte La prise en charge des SCA ST+ est un enjeu majeur de sante publique. La precocite de la reperfusion permet de diminuer la mortalite et les morbidites associees a la necrose myocardique. Chaque annee, environ 150 patients presentant un SCA ST+ sont pris en charge par le SMUR de Lille. Ils doivent beneficier d9une strategie de reperfusion en urgence que ce soit une thrombolyse IV des la phase pre-hospitaliere ou une angioplastie primaire en salle de catheterisme. Programme Ce travail a permis de realiser une « Evaluation de Pratiques Professionnelles » transversale entre le SAMU 59 et le service des soins intensifs cardiologiques du CHRU de Lille. Un audit cible de dossiers a ete realise. Les dossiers du registre ESTIM, auquel le SAMU59 participe depuis 2001 ont ete utilises. Un tirage au sort de 20 dossiers sur les 6 premiers mois de l9annee 2006 a ete realise. Ces dossiers ont ete compares au referentiel RPC/HAS: « Syndromes coronariens Aigus » Des medecins urgentistes et des cardiologues directement impliques dans la prise en charge des patients ont participe a cette evaluation. Le taux de reperfusion, la technique choisie, les delais selon la technique de reperfusion ont ete etudies. Resultats L9ASA est administre dans 90% des cas. Le taux de reperfusion est de 75%: 12 thrombolyses, 3 angioplasties primaires (ATLP), 5 patients non reperfuses. En cas de thrombolyse, elle est realisee dans les 30 min apres l9ECG qualifiant dans 100% des cas; par contre en cas d9angioplastie primaire, les patients ne sont pas directement deposes sur la table de coronarographie et le delai global de 90 min recommandes n9est pas respecte. De ce fait, le chemin clinique a ete modifie, en cas de decision d9angioplastie primaire les patients arrivent directement en salle de catheterisme. Le partenariat public-prive a ete renforce afin d9ameliorer la disponibilite des tables de coronarographie. Une seconde evaluation a ete realisee en etudiant les memes indicateurs de reperfusion. 18 dossiers de SCA ST+ ont ete analyses. L9ASA est alors administre dans 100% des cas. Le taux de reperfusion est de 100%. 12 patients ont beneficie d9une thrombolyse pre hospitaliere et 12 d9une angioplastie primaire. 50% des patients en ATLP ont un delai (ECG qualifiant-ballon) inferieur a 90 min. Les 6 autres patients ont presentes des complications lors de la prise en charge necessitant une prise en charge plus lourde. Conclusion Les grilles d9evaluation, validees par la HAS en 2008 et mises a disposition des praticiens, permettent de diriger l9EPP sur des indicateurs consensuels. La reperfusion en urgence d9un SCA ST + est un defi contre le temps. Elle implique tous les acteurs de la prise en charge depuis le medecin regulateur du SAMU, qui declenche et coordonne l9envoi des moyens, jusqu9au cardiologue realisant l9angioplastie en passant par le medecin urgentiste du SMUR. L9EPP permet de deceler « les failles » d9un systeme de prise en charge ou le choix d9une strategie et le delai de mise en œuvre de celle-ci sont des elements qui conditionnent directement la mortalite en phase aigue. Le choix d9une strategie de reperfusion adaptee a chaque patient et a son environnement est un gage de qualite en terme de prise en charge des SCA ST+.